Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

miR-486 may help prevent hair loss in alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

CCL5 is important for the hair growth potential of human dermal papilla cells.

CD133+ cells are crucial for hair growth.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Melanocyte progenitor cells are found in human fat tissue and can become mature melanocytes, which may help treat skin issues.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Only 40 nm nanoparticles can enter skin cells effectively for potential vaccine delivery.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

M-CSF-stimulated myeloid cells can turn into skin cells and help heal wounds and regrow hair.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

The treatments stopped hair regrowth in mice.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

CD2 might be a new treatment target for patchy alopecia areata.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Scientists found markers called CD34 and CD200 that help identify stem cells in mouse and human hair follicles.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

CD98hc's role in skin health decreases with age.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.